#United States #New York #Class Action #Inc. #Co-Diagnostics #Stadium Capital LLC

Proposed Settlement Notice in Class Action

In a significant development concerning the financial interests of investors, the United States District Court for the Southern District of New York has announced a proposed settlement related to a class-action lawsuit involving Co-Diagnostics, Inc. This case was brought forward on behalf of Stadium Capital LLC, representing all affected parties who purchased shares or options during a specified time frame.

Overview of the Class Action

The lawsuit specifically targets actions taken by Co-Diagnostics between May 12, 2022, and August 11, 2022. During this period, shareholders who acquired common stock or options may have faced financial losses due to potential misrepresentations or omissions of material facts. The court has documented that a total settlement sum of $6.5 million is proposed, pending approval from the presiding Judge Arun Subramanian.

Hearing Schedule and Purpose

A formal hearing is scheduled for December 8, 2026, at 2:00 p.m. in the Southern District of New York. The objectives of this hearing include:

• - Evaluating whether the proposed settlement is fair and reasonable.
• - Assessing the dismissal of claims against the defendants.
• - Analyzing the plan for distributing the settlement funds.
• - Reviewing the lead counsel’s request for an award of attorneys’ fees and reimbursement of litigation expenses.

This hearing provides a crucial opportunity for affected shareholders to voice their opinions, either in favor of or against the settlement.

Your Rights as a Class Member

Shareholders who fall under the definition of Class members are encouraged to take note of the upcoming settlement proceedings. If you have purchased shares of Co-Diagnostics or participated in related options during the outlined period, your rights are pertinent to the outcome of this case.

To share in the settlement fund, affected parties must submit a Claim Form by January 6, 2027. This is a critical step, as failure to do so could mean forfeiting any potential recovery while still being subject to the Court's final judgments.

Weighing Options—Objecting or Excluding

Class members have the choice to either object to the terms of the settlement or opt out completely. Should you choose to object, your written opinions must be submitted as outlined in the detailed court notice. Alternatively, if you decide to exclude yourself from the class, you must act by submitting a request for exclusion. This decision allows you to pursue other potential legal actions but has risks, including statutory limitations on claims.

Conclusion

As stakeholders prepare for the December hearing, keeping informed about the procedures and timelines is essential. Those with questions regarding the settlement or the claims process are advised to reach out directly to the lead counsel for further clarification. The upcoming court session is a vital juncture for everyone involved, emphasizing transparency and facilitating a fair resolution for affected investors. For more detailed inquiries and updates, shareholders may refer to the Claims Administrator or the court-appointed lead counsel, ensuring they remain apprised of vital information as it unfolds.